Metastatic Uveal Melanoma Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03472586Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the LiverTreatment
NCT04552223Nivolumab Plus Relatlimab in Patients With Metastatic Uveal MelanomaTreatment